Plain-English translation of NCT07594119 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help reduce focal seizures in adults with epilepsy. You would take the medication as a daily pill, alongside the seizure drugs you're already taking. The study will compare how well the medication works at two different doses, compared to a placebo (a pill with no active ingredient).
Many people with focal epilepsy still have seizures even when taking one or more seizure medications. This trial is exploring whether this new treatment could offer better seizure control for patients who need additional help managing their condition.
You likely qualify if…
You likely don't qualify if…
You would visit the study site multiple times over several months. At each visit, the team will check your health, review your seizure records from your e-diary, and give you your daily medication or placebo pills to take at home. After the main study period ends, you can choose to either join a longer follow-up study to continue receiving the medication, or complete an 8-week period where you stop taking it while the team monitors you.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
United States